Rose-Marie Sjöberg

Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor Treatment
Niloufar Javanmardi, Susanne Fransson, Anna Djos, Rose-Marie Sjöberg, Staffan Nilsson et al.
Scientific Reports, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Characterization of amplicon junction sequences in genomic regions surrounding the MYCN gene in neuroblastoma tumors; implications for clinical follow-up of high-risk patients
Hanna Kryh, Jonas Abrahamsson, Elsa Jegerås, Rose-Marie Sjöberg, I Devenney et al.
FEBS Journal, Paper i proceeding 2011
Paper i proceeding

Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
Helena Carén, Anna Djos, Maria Nethander, Rose-Marie Sjöberg, Per Kogner et al.
BMC Cancer, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

MYCN amplicon junctions as tumor-specific targets for minimal residual disease detection in neuroblastoma.
Hanna Kryh, Jonas Abrahamsson, Elsa Jegerås, Rose-Marie Sjöberg, Irene Devenney et al.
International journal of oncology, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors.
Hanna Kryh, Helena Carén, Jennie Erichsen, Rose-Marie Sjöberg, Jonas Abrahamsson et al.
BMC genomics, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.
Helena Carén, Hanna Kryh, Maria Nethander, Rose-Marie Sjöberg, Catarina Träger et al.
PNAS, Artikel i vetenskaplig tidskrift 2010
Artikel i vetenskaplig tidskrift

The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2A.
Annica Wilzén, Staffan Nilsson, Rose-Marie Sjöberg, Per Kogner, Tommy Martinsson et al.
International journal of oncology, Artikel i vetenskaplig tidskrift 2009
Artikel i vetenskaplig tidskrift

Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumorigenesis
Cecilia Krona, Helena Carén, Rose-Marie Sjöberg, Bengt Sandstedt, Genevieve Laureys et al.
International Journal of Oncology, Artikel i vetenskaplig tidskrift 2008
Artikel i vetenskaplig tidskrift

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors; Four cases of homozygous deletions of the CDKN2A gene.
Helena Carén, Jennie Erichsen, Linda Olsson, Charlotta Enerbäck, Rose-Marie Sjöberg et al.
BMC Genomics, Artikel i vetenskaplig tidskrift 2008
Artikel i vetenskaplig tidskrift

Significant Decrease in mRNA Expression of Five Genes Mapped at 1p36.2, comparing Favorable and Unfavorable Neuroblastomas.
Susanne Fransson, Cecilia Krona, Rose-Marie Sjöberg, Frida Abel, Tommy Martinsson et al.
Advances in Neuroblastoma Research 2006, Los Angeles, USA, 2006, Konferensbidrag (offentliggjort, men ej förlagsutgivet) 2006
Konferensbidrag (offentliggjort, men ej förlagsutgivet)

Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor Treatment
Niloufar Javanmardi, Susanne Fransson, Anna Djos, Rose-Marie Sjöberg, Staffan Nilsson et al.
Scientific Reports, Artikel i vetenskaplig tidskrift 2019
Artikel i vetenskaplig tidskrift

Characterization of amplicon junction sequences in genomic regions surrounding the MYCN gene in neuroblastoma tumors; implications for clinical follow-up of high-risk patients
Hanna Kryh, Jonas Abrahamsson, Elsa Jegerås, Rose-Marie Sjöberg, I Devenney et al.
FEBS Journal, Paper i proceeding 2011
Paper i proceeding

Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
Helena Carén, Anna Djos, Maria Nethander, Rose-Marie Sjöberg, Per Kogner et al.
BMC Cancer, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

MYCN amplicon junctions as tumor-specific targets for minimal residual disease detection in neuroblastoma.
Hanna Kryh, Jonas Abrahamsson, Elsa Jegerås, Rose-Marie Sjöberg, Irene Devenney et al.
International journal of oncology, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors.
Hanna Kryh, Helena Carén, Jennie Erichsen, Rose-Marie Sjöberg, Jonas Abrahamsson et al.
BMC genomics, Artikel i vetenskaplig tidskrift 2011
Artikel i vetenskaplig tidskrift

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.
Helena Carén, Hanna Kryh, Maria Nethander, Rose-Marie Sjöberg, Catarina Träger et al.
PNAS, Artikel i vetenskaplig tidskrift 2010
Artikel i vetenskaplig tidskrift

The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2A.
Annica Wilzén, Staffan Nilsson, Rose-Marie Sjöberg, Per Kogner, Tommy Martinsson et al.
International journal of oncology, Artikel i vetenskaplig tidskrift 2009
Artikel i vetenskaplig tidskrift

Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumorigenesis
Cecilia Krona, Helena Carén, Rose-Marie Sjöberg, Bengt Sandstedt, Genevieve Laureys et al.
International Journal of Oncology, Artikel i vetenskaplig tidskrift 2008
Artikel i vetenskaplig tidskrift

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors; Four cases of homozygous deletions of the CDKN2A gene.
Helena Carén, Jennie Erichsen, Linda Olsson, Charlotta Enerbäck, Rose-Marie Sjöberg et al.
BMC Genomics, Artikel i vetenskaplig tidskrift 2008
Artikel i vetenskaplig tidskrift

Significant Decrease in mRNA Expression of Five Genes Mapped at 1p36.2, comparing Favorable and Unfavorable Neuroblastomas.
Susanne Fransson, Cecilia Krona, Rose-Marie Sjöberg, Frida Abel, Tommy Martinsson et al.
Advances in Neuroblastoma Research 2006, Los Angeles, USA, 2006, Konferensbidrag (offentliggjort, men ej förlagsutgivet) 2006
Konferensbidrag (offentliggjort, men ej förlagsutgivet)